SPEC PerkinElmer 11.10
News|Articles|June 18, 2024

Advancements in Raman Spectroscopy Propel Biomedical Science Forward

Author(s)Will Wetzel
Fact checked by: Caroline Hroncich

A recent study published in Food Frontiers shows how Raman spectroscopy is being applied in biomedical sciences and what it means for the industry moving forward.

Biomedical sciences are benefitting from the increased inclusion of Raman spectroscopy in tissue analysis, according to a recent study published in Food Frontiers (1).

Raman spectroscopy is a non-destructive and highly sensitive technique that analyzes biological tissues by providing detailed spectral information about specific molecular structures (2). This method has garnered recognition for its effectiveness in diagnosing a variety of diseases, such as cancer, infections, and neurodegenerative conditions, and predicting surgical outcomes (1).

A multidisciplinary study done by researchers from Macau University of Science and Technology, Harvard Medical School, Purdue University, Suzhou University of Science and Technology, China University of Mining and Technology, and Beijing University of Posts and Telecommunications, explored the many ways Raman spectroscopy is being used in biomedical applications.

The research presents an extensive overview of state-of-the-art techniques in Raman spectroscopy, focusing on innovations like surface-enhanced Raman spectroscopy (SERS), resonance Raman spectroscopy, and tip-enhanced Raman spectroscopy and what these developments have helped enhance. In particular, the research team pointed out how these advancements have shown significant promise in both ex vivo and in vivo medical diagnoses (1).

The researchers discussed in their article how the strengths of Raman spectroscopy make it suitable for application in clinical diagnosis. Raman spectroscopy has the ability to perform label-free and highly sensitive analysis of biomolecules (1). Despite some challenges, the robustness of Raman scattering techniques is poised to expand their diagnostic scope to cover more types of tissue lesions (1).

The study identified several promising future directions for Raman spectroscopy in biomedical applications. One key area is the identification of specific molecular markers for different lesions in human tissue samples (1). Establishing clear relationships between these markers and specific diseases could significantly enhance diagnostic accuracy (1). Additionally, advanced data processing techniques are crucial for extracting meaningful information from the complex spectral data obtained through Raman spectroscopy. Machine learning (ML) has emerged as a vital tool for this purpose, offering unprecedented opportunities to analyze large spectroscopic data sets (1). However, the performance of ML models is highly dependent on the quality of the features used for classification, necessitating extensive feature extraction and selection (1).

In addition to the identification of specific molecular markers for different lesions in human tissue samples, Raman spectroscopy shows potential in diagnosing infectious diseases. The ability of the technique to analyze oxidative stress processes, which often precede pathological or oncological conditions, is notable. These processes can influence the interpretation of spectral data, highlighting the need for comprehensive analysis when using Raman/SERS-based methodologies (1).

However, the final part of the study highlighted the challenges that exist using Raman and SERS-based methodologies in clinical applications. For example, issues such as biocompatibility and toxicity of nanoparticles (NPs) or substrates used in SERS need to be addressed (1).

Another challenge that will need to be solved is reproducibility. The consistency of results can be influenced by the substrate used, prompting the development of standardized protocols for substrate fabrication (1). Innovations in substrate materials and surface modifications are also being explored to enhance reliability and reproducibility (1).

Moreover, the clinical translation of Raman spectroscopy is hindered by factors such as laser safety. High power or long integration times are often required to overcome the weak Raman signal in vivo, posing a risk of tissue damage (1). To that end, researchers are developing approaches to optimize laser parameters, including wavelength and power, to ensure safety while maintaining an adequate signal-to-noise ratio (SNR).

References

(1) Qi, Y.; Chen, E. X.; Hu, D.; et al. Applications of Raman Spectroscopy in Clinical Medicine. Food Frontiers 2024, 5 (2), 392–419. DOI: 10.1002/fft2.335

(2) Horiba Scientific, What is Raman Spectroscopy? Horiba Scientific. Available at: https://www.horiba.com/int/scientific/technologies/raman-imaging-and-spectroscopy/raman-spectroscopy/#:~:text=Raman%20Spectroscopy%20is%20a%20non,chemical%20bonds%20within%20a%20material. (accessed 2024-06-14).


Related to this article

Work of the surgeon in the hospital operating room. Concentrated doctor with glasses. | Image Credit: © velimir - stock.adobe.com
Jürgen Popp explains how head and neck surgeons in Jena use a Raman probe to locate tumor borders, why the technique could replace frozen section biopsies, and why optical tools must adapt to clinical workflows rather than the other way around.
Healthcare administrator reviewing an insurance policy schedule with a stethoscope on a clipboard, health insurance coverage, medical underwriting, prior authorization, and patient claims processing. | Image Credit: Joi_studio - stock.adobe.com
In a SciX interview, Marc Porter covered a lot of ground, from a student-driven pivot into immunoassays to a baseball analogy for Stokes and anti-Stokes scattering, and shares the open questions he is still chasing.
Spectral Frontiers: Seeing the Unseeable Microspectroscopy
Microspectroscopy, the marriage of spectroscopic chemical identification with microscopic spatial resolution, has advanced from Perkin-Elmer's first commercial infrared microspectrometer in 1953 to today's nanoscale AFM-IR probes, synchrotron-brightness infrared beamlines, and compact hyperspectral tissue imaging devices being developed for AI-assisted cancer detection.
Highlights from What’s Nu October 2026
In this Q&A, we recap the October edition of “What’s Nu,” which covered topics such as how novel spectroscopic and analytical methods are transforming environmental monitoring, medical treatment, and accessibility in scientific research.